Auayporn Nademanee

12.4k total citations · 4 hit papers
180 papers, 7.3k citations indexed

About

Auayporn Nademanee is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, Auayporn Nademanee has authored 180 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pathology and Forensic Medicine, 89 papers in Hematology and 84 papers in Oncology. Recurrent topics in Auayporn Nademanee's work include Lymphoma Diagnosis and Treatment (101 papers), Hematopoietic Stem Cell Transplantation (78 papers) and Viral-associated cancers and disorders (48 papers). Auayporn Nademanee is often cited by papers focused on Lymphoma Diagnosis and Treatment (101 papers), Hematopoietic Stem Cell Transplantation (78 papers) and Viral-associated cancers and disorders (48 papers). Auayporn Nademanee collaborates with scholars based in United States, Taiwan and Singapore. Auayporn Nademanee's co-authors include Stephen J. Forman, Patrick J. Stiff, Richard T. Maziarz, John F. DiPersio, Ivana N. Micallef, Gary Bridger, Ravi Bhatia, Joyce C. Niland, Anthony S. Stein and Brian J. Bolwell and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Auayporn Nademanee

177 papers receiving 7.1k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

2013 609 citations Zheng Zhou, Alfred Rademaker et al. Blood profile →
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

2009 579 citations John F. DiPersio, Auayporn Nademanee et al. Blood profile →
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 477 citations Auayporn Nademanee, Patrick J. Stiff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Auayporn Nademanee United States	39	3.3k	3.2k	3.1k	1.3k	1.3k	180	7.3k
Ivana N. Micallef United States	45	3.2k 1.0×	3.3k 1.0×	2.9k 0.9×	1.7k 1.3×	1.6k 1.2×	256	7.4k
Philip J. Bierman United States	48	3.2k 1.0×	3.9k 1.2×	1.6k 0.5×	1.8k 1.4×	933 0.7×	210	6.5k
Patrick J. Stiff United States	46	4.1k 1.2×	2.3k 0.7×	3.2k 1.0×	1.2k 1.0×	1.3k 1.0×	247	8.4k
John Kuruvilla Canada	34	4.4k 1.3×	3.8k 1.2×	1.3k 0.4×	1.5k 1.1×	1.4k 1.1×	295	7.1k
Réda Bouabdallah France	34	4.3k 1.3×	5.7k 1.8×	1.3k 0.4×	2.4k 1.8×	1.6k 1.2×	126	8.2k
Marco Ladetto Italy	42	2.9k 0.9×	4.2k 1.3×	1.6k 0.5×	1.7k 1.3×	1.2k 0.9×	175	7.2k
Silvia Montoto United Kingdom	41	2.8k 0.9×	3.1k 1.0×	1.4k 0.5×	1.3k 1.0×	785 0.6×	165	5.2k
Michinori Ogura Japan	43	3.0k 0.9×	3.2k 1.0×	1.5k 0.5×	1.8k 1.4×	2.2k 1.7×	223	7.3k
David J. Inwards United States	49	3.8k 1.1×	4.4k 1.4×	1.9k 0.6×	2.1k 1.6×	1.7k 1.3×	265	8.0k
Luis F. Porrata United States	43	2.6k 0.8×	2.4k 0.8×	1.7k 0.5×	1.4k 1.1×	1.5k 1.1×	211	5.4k

Countries citing papers authored by Auayporn Nademanee

Since Specialization

Citations

This map shows the geographic impact of Auayporn Nademanee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Auayporn Nademanee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Auayporn Nademanee more than expected).

Fields of papers citing papers by Auayporn Nademanee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Auayporn Nademanee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Auayporn Nademanee. The network helps show where Auayporn Nademanee may publish in the future.

Co-authorship network of co-authors of Auayporn Nademanee

This figure shows the co-authorship network connecting the top 25 collaborators of Auayporn Nademanee. A scholar is included among the top collaborators of Auayporn Nademanee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Auayporn Nademanee. Auayporn Nademanee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciurea, Stefan O., Monzr M. Al Malki, Piyanuch Kongtim, et al.. (2021). Treatment of allosensitized patients receiving allogeneic transplantation. Blood Advances. 5(20). 4031–4043. 34 indexed citations

Zain, Jasmine M., Jennifer Simpson, Joycelynne Palmer, et al.. (2020). Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Mature T-Cell NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen". Blood. 136(Supplement 1). 10–11. 1 indexed citations

Malki, Monzr M. Al, Joo Y. Song, Dongyun Yang, et al.. (2020). Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(9). 1697–1703. 9 indexed citations

Salhotra, Amandeep, Liana Nikolaenko, Lu Chen, et al.. (2019). Outcomes of Patients with T-Lymphoblastic Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center. Blood. 134(Supplement_1). 5729–5729. 1 indexed citations

Malki, Monzr M. Al, Sanjeet Dadwal, Dongyun Yang, et al.. (2017). High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes. Blood. 130. 4494. 7 indexed citations

Malki, Monzr M. Al, Joo Y. Song, Dongyun Yang, et al.. (2017). Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT). Blood. 130. 3212–3212. 2 indexed citations

Herrera, Alex F., Allison Crosby‐Thompson, Jonathan W. Friedberg, et al.. (2014). Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network. Cancer. 120(13). 1993–1999. 27 indexed citations

Mei, Matthew, Mariëlle J. Wondergem, Joycelynne Palmer, et al.. (2014). Autologous Transplantation for Transformed Non-Hodgkin Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen. Biology of Blood and Marrow Transplantation. 20(12). 2072–2075. 11 indexed citations

Zhou, Zheng, Alfred Rademaker, Leo I. Gordon, et al.. (2014). High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender. Blood. 124(21). 3046–3046. 1 indexed citations

10.

Yuan, Shan, Auayporn Nademanee, Amrita Krishnan, et al.. (2013). Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent. Transfusion. 53(12). 3244–3250. 7 indexed citations

11.

DiPersio, John F., Ivana N. Micallef, Patrick J. Stiff, et al.. (2009). Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology. 27(28). 4767–4773. 512 indexed citations breakdown →

12.

Nademanee, Auayporn. (2009). Transplantation for non-Hodgkin lymphoma. Expert Review of Hematology. 2(4). 425–442. 4 indexed citations

13.

Bhatia, Ravi, Liton Francisco, Andrea Carter, et al.. (2007). Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 110(10). 3784–3792. 374 indexed citations

14.

Krishnan, Amrita, Joycelynne Palmer, Auayporn Nademanee, et al.. (2007). The Impact of Incorporating Targeted Radioimmunotherapy (RIT) into Transplant Preparative Regimens on the Incidence of Therapy Related Myelodysplasia (t-MDS) or AML (t-AML) Following Autologous Stem Cell Transplant (ASCT) for Lymphoma.. Blood. 110(11). 1082–1082. 2 indexed citations

15.

Molina, Arturo, Amrita Krishnan, Henry C. Fung, et al.. (2007). Use of Radioimmunotherapy in Stem Cell Transplantation and Posttransplantation: Focus on Yttrium 90 Ibritumomab Tiuxetan. Current Stem Cell Research & Therapy. 2(3). 239–248. 7 indexed citations

16.

Rodríguez, Roberto, Auayporn Nademanee, Nora Ruel, et al.. (2006). Comparison of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodgkin’s Lymphoma. Biology of Blood and Marrow Transplantation. 12(12). 1326–1334. 76 indexed citations

17.

Jaing, Tang‐Her, Joseph Rosenthal, Auayporn Nademanee, et al.. (2006). Hematopoietic Stem Cell Transplantation (HSCT) Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Cell Depleted.. Blood. 108(11). 5231–5231.

18.

Krishnan, Amrita, Ravi Bhatia, Marilyn L. Slovak, et al.. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 95(5). 1588–1593. 205 indexed citations

19.

Op, Sharma, et al.. (1987). Sarcoidosis and lymphoma: an unusual association.. PubMed. 4(1). 58–63. 9 indexed citations

20.

Spruce, Wayne E., Stephen J. Forman, Robert A. Krance, et al.. (1984). Outcome of bone marrow transplantation in patients with extramedullary involvement of acute leukemia. Annals of Hematology. 48(2). 75–79. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact